Skip to content
Search

Latest Stories

Creating smokefree generation: MPs to vote on Tobacco and Vapes Bill today

Creating smokefree generation: MPs to vote on Tobacco and Vapes Bill today

If passed, the bill will help deliver Prime Minister Rishi Sunak’s commitment to creating a smokefree generation

Today, the UK will move one step closer to realising the vision of a smokefree generation as members of parliament (MPs) are poised to vote on the Tobacco and Vapes Bill.

The landmark bill proposed making it illegal to sell tobacco products to anyone born after 1 January 2009.


If passed, not only will it protect children turning 15 this year or younger from the harms of smoking, but it will also ease the strain on our NHS and improve the UK’s productivity.

Smoking is considered the single biggest preventable killer in the UK, accounting for around 80,000 deaths annually.

According to the Department of Health and Social Care (DHSC), smoking costs the NHS and economy an estimated £17 billion each year, surpassing the £10 billion annual revenue from tobacco taxation.

It is believed that the bill will contribute to fulfilling the Prime Minister’s commitment to creating a smokefree generation, potentially preventing more than 470,000 cases of heart disease, stroke, lung cancer, and other deadly diseases by the end of the century.

Health and Social Care Secretary, Victoria Atkins, said: “The truth is that there is no safe level of tobacco consumption. It is uniquely harmful and that is why we are taking this important action today to protect the next generation.

“This bill will save thousands of lives, ease the strain on our NHS and improve the UK’s productivity.”

To address youth vaping, the bill also proposes imposing restrictions on flavours and regulations on the sale and packaging of vapes to reduce their appeal to children.

Smoking is highly addictive, with four out of five smokers starting the habit before the age of 20 and remaining addicted for the rest of their lives despite the majority attempting to quit at some point, the DHSC noted.

In England, an individual with a smoking-related condition is hospitalised nearly every minute.

Public Health Minister Andrea Leadsom, said: “Because the case against these harmful products is so strong, it’s not surprising that the majority of the British public - including those who smoke and those who sell tobacco - support plans to protect the next generation from the misery of smoking.

“Our plan will save lives, ease the strain on our NHS and ensure a brighter future for our children.”

Alongside action to prevent creating future smokers, the government has already announced significant additional funding for stop smoking services over the next 5 years, effectively doubling the money available for local initiatives that can help existing smokers to quit. The government is also rolling out an innovative financial incentives scheme to help all pregnant smokers to quit.

Moreover, the government is introducing an innovative financial incentives scheme to help all pregnant smokers to quit.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less